National Cancer Centre Singapore-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Cancer Centre Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013369
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Cancer Centre Singapore (NCCS) is a healthcare service provider that offers research and cancer treatment services. The center offers research for cancers such as breast, gynaecology, haematology, head and neck, neuro oncology, naso pharynx cancer, paediatrics, reconstructive, hepatobiliary, lymphoma, musculoskeletal and colorectal. It provides genetic counselling, risk evaluation and prevention and geriatric oncology. NCCS medical diagnosis, treatment and care for all cancer patients. The center also offers research facility consists of genetic microarray system, flow cytometry, confocal microscopy, DNA sequencing, animal holding rooms, and others. It also provides training programs for oncologists, researchers, clinician scientists and health professionals. NCCS is headquartered in Singapore.

National Cancer Centre Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Cancer Centre Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Cancer Centre Singapore, Medical Devices Deals, 2011 to YTD 2017 9
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
immunoSCAPE to Enter into Agreement with National Cancer Centre 11
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 12
Aslan Pharma Enters into MoU with National Cancer Centre Singapore 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
National Cancer Centre Singapore – Key Competitors 15
National Cancer Centre Singapore – Key Employees 16
National Cancer Centre Singapore – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Mar 16, 2017: Doctors a step closer to giving liver cancer patients a more precise treatment 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Key Facts 2
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Cancer Centre Singapore, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Cancer Centre Singapore, Deals By Therapy Area, 2011 to YTD 2017 8
National Cancer Centre Singapore, Medical Devices Deals, 2011 to YTD 2017 9
National Cancer Centre Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
immunoSCAPE to Enter into Agreement with National Cancer Centre 11
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 12
Aslan Pharma Enters into MoU with National Cancer Centre Singapore 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
National Cancer Centre Singapore, Key Competitors 15
National Cancer Centre Singapore, Key Employees 16

★海外企業調査レポート[National Cancer Centre Singapore-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Srei Infrastructure Finance Ltd
    Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report Summary Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bioderm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioderm Inc (Bioderm) is a medical equipment company that manufactures designs, and markets hydrocolloid products. The company manufactures hydrocolloid products for urinary management, securement, infection control, and skin protection. Its products include cathgrip, bioplus+, freederm, men …
  • The Cooper Companies, Inc.:企業の戦略・SWOT・財務情報
    The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • TOTAL S.A.:企業の戦略・SWOT・財務情報
    TOTAL S.A. - Strategy, SWOT and Corporate Finance Report Summary TOTAL S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Broad Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Reynolds American Inc.:企業の戦略的SWOT分析
    Reynolds American Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • NAPEC Inc (NPC):企業の財務・戦略的SWOT分析
    NAPEC Inc (NPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • PT PLN (Persero):発電所・企業SWOT分析
    PT PLN (Persero) – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Bristol-Myers Squibb Co (BMY)-医療機器分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • AFFiRiS AG-製薬・医療分野:企業M&A・提携分析
    Summary Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer's disease, Parkinson's disease, a …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hrvatski Telekom d.d. (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom d.d. (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆